Organic Chemicals: News and Research on Hydrocarbons, Halogenated

MeSH tree: D02.455.526

PCSK9, statin combo may cut cholesterol post-transplant

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late-breaking science presentation ...

Common toxin linked to liver disease

Liver disease is usually caused by one of three factors: alcohol consumption, fat buildup in the liver linked to obesity, diabetes and high cholesterol, or hepatitis B and C.

page 3 from 13